DK164256C - Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf - Google Patents

Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf

Info

Publication number
DK164256C
DK164256C DK400685A DK400685A DK164256C DK 164256 C DK164256 C DK 164256C DK 400685 A DK400685 A DK 400685A DK 400685 A DK400685 A DK 400685A DK 164256 C DK164256 C DK 164256C
Authority
DK
Denmark
Prior art keywords
preparation
drug
preparing
procedure
controlled release
Prior art date
Application number
DK400685A
Other languages
English (en)
Other versions
DK164256B (da
DK400685D0 (da
DK400685A (da
Inventor
Bo Magnus Ekman
Aake Rikard Lindahl
Original Assignee
Gacell Lab Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gacell Lab Ab filed Critical Gacell Lab Ab
Publication of DK400685D0 publication Critical patent/DK400685D0/da
Publication of DK400685A publication Critical patent/DK400685A/da
Publication of DK164256B publication Critical patent/DK164256B/da
Application granted granted Critical
Publication of DK164256C publication Critical patent/DK164256C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
DK400685A 1984-09-06 1985-09-02 Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf DK164256C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8404467A SE8404467D0 (sv) 1984-09-06 1984-09-06 Controlled-release medical preparations
SE8404467 1984-09-06

Publications (4)

Publication Number Publication Date
DK400685D0 DK400685D0 (da) 1985-09-02
DK400685A DK400685A (da) 1986-03-07
DK164256B DK164256B (da) 1992-06-01
DK164256C true DK164256C (da) 1992-10-19

Family

ID=20356934

Family Applications (1)

Application Number Title Priority Date Filing Date
DK400685A DK164256C (da) 1984-09-06 1985-09-02 Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf

Country Status (21)

Country Link
US (1) US4824678A (da)
EP (1) EP0173928B1 (da)
JP (1) JP2527713B2 (da)
KR (1) KR930003114B1 (da)
AT (1) ATE53490T1 (da)
AU (1) AU576891B2 (da)
CA (1) CA1252723A (da)
DE (1) DE3578123D1 (da)
DK (1) DK164256C (da)
ES (1) ES8702138A1 (da)
FI (1) FI87042C (da)
GR (1) GR852158B (da)
HU (1) HU194495B (da)
IE (1) IE58263B1 (da)
IL (2) IL76257A (da)
NO (1) NO169996C (da)
NZ (1) NZ213245A (da)
PH (1) PH22119A (da)
PT (1) PT81092B (da)
SE (1) SE8404467D0 (da)
ZA (1) ZA856547B (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
EP0153105B1 (en) * 1984-02-10 1992-09-09 Benzon Pharma A/S Diffusion coated multiple-units dosage form
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
US5240601A (en) * 1988-11-09 1993-08-31 Chembiomed, Ltd. Affinity supports for hemoperfusion
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
EP0688429B1 (en) * 1993-03-09 1998-02-11 Epic Therapeutics, Inc.. Macromolecular microparticles and methods of production
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
AU2277101A (en) 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SK287105B6 (sk) 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
ATE477795T1 (de) * 2001-07-04 2010-09-15 Sun Pharma Advanced Res Co Ltd Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
SI1355633T1 (en) * 2001-12-19 2005-06-30 Astrazeneca Ab NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate
EP1485078B1 (en) * 2002-03-15 2012-09-26 Cypress Bioscience, Inc. Milnacipran for the treatment of irritable bowel syndrome
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
GB0227948D0 (en) * 2002-11-29 2003-01-08 Cipla Ltd Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7862835B2 (en) * 2004-10-27 2011-01-04 Boston Scientific Scimed, Inc. Method of manufacturing a medical device having a porous coating thereon
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
EP1948132B1 (en) * 2005-11-18 2009-08-05 Synhton B.V. Zolpidem tablets
US7427414B2 (en) * 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
CN102440992A (zh) * 2011-12-19 2012-05-09 岳阳新华达制药有限公司 含有盐酸班布特罗和多索茶碱复方制剂及其制备方法
EP3331502B1 (en) 2015-08-07 2021-05-26 Santa Farma Ilaç Sanayi A.S. Controlled release propiverine formulations
EP3796908B1 (en) 2018-11-16 2023-05-10 Santa Farma Ilaç Sanayi A.S. Controlled release propiverine formulations
EP4251154A1 (en) 2020-11-27 2023-10-04 Santa Farma Ilac Sanayii A.S. Sustained release formulation compositions comprising propiverine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL108838C (da) * 1956-03-27
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
EP0013131A3 (en) * 1978-12-27 1981-01-07 Mundipharma A.G. Pharmaceutical composition in solid dosage form, and process for its production
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system

Also Published As

Publication number Publication date
JP2527713B2 (ja) 1996-08-28
DE3578123D1 (de) 1990-07-19
DK164256B (da) 1992-06-01
ATE53490T1 (de) 1990-06-15
EP0173928A1 (en) 1986-03-12
DK400685D0 (da) 1985-09-02
HUT40333A (en) 1986-12-28
DK400685A (da) 1986-03-07
ES546728A0 (es) 1986-12-16
SE8404467D0 (sv) 1984-09-06
NO169996C (no) 1992-09-02
IE58263B1 (en) 1993-08-25
FI853406L (fi) 1986-03-07
KR930003114B1 (ko) 1993-04-19
IL76256A (en) 1990-06-10
JPS61112013A (ja) 1986-05-30
IL76256A0 (en) 1986-01-31
ZA856547B (en) 1986-04-30
HU194495B (en) 1988-02-29
IE852070L (en) 1986-03-06
FI87042B (fi) 1992-08-14
GR852158B (da) 1986-01-08
PT81092B (pt) 1988-01-22
PH22119A (en) 1988-06-01
NO853407L (no) 1986-03-07
EP0173928B1 (en) 1990-06-13
CA1252723A (en) 1989-04-18
NO169996B (no) 1992-05-25
AU4693585A (en) 1986-03-13
US4824678A (en) 1989-04-25
IL76257A (en) 1989-05-15
AU576891B2 (en) 1988-09-08
FI853406A0 (fi) 1985-09-05
ES8702138A1 (es) 1986-12-16
NZ213245A (en) 1988-06-30
PT81092A (en) 1985-10-01
FI87042C (fi) 1992-11-25
KR860002271A (ko) 1986-04-24

Similar Documents

Publication Publication Date Title
DK164256C (da) Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf
HUT59321A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
NO863997D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
ATE150963T1 (de) Kugelförmige granula mit kern sowie deren herstellung
ES2001897A6 (es) Procedimiento para la fabricacion de una tableta de liberacion controlada
HUT56267A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
IE883810L (en) Sustained release pharmaceutical compositions
EP0158277A3 (de) Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung
KR880001289A (ko) 서방성 제제 및 그의 제조방법
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
ES2029789T3 (es) Metodo para obtener un preparado farmaceutico de liberacion prolongada.
EP0171528A3 (en) Controlled release pharmaceutical preparations
SE8803822A (da)
NO170424C (no) Harpikspartikler av desintegrasjonstypen, deres fremstilling og beleggsmiddel inneholdende slike partikler
ES500670A0 (es) Procedimiento de preparar farmacos con liberacion programada de materia activa.

Legal Events

Date Code Title Description
PBP Patent lapsed